Telmis­ar­tan CAS 144701-48-4

Iden­ti­fi­ca­tion Prop­er­ties Safe­ty Data Spec­i­fi­ca­tions & Oth­er Information Links

Iden­ti­fi­ca­tion

CAS Number

144701-48-4

Name

Telmis­ar­tan

Syn­onyms

[1,1′-Biphenyl]-2-carboxylic acid, 4′-[(1,4′-dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]- [ACD/​Index Name] 144701-48-4 [RN] 4′-[(1,7′-Dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]-2-biphenylcarbonsäure [Ger­man] [ACD/IUPAC Name] 4′-[(1,7′-Dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]-2-biphenylcarboxylic acid [ACD/IUPAC Name] 4′-[(1,7′-Dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]biphenyl-2-carbonsäure [Ger­man] 4′-[(1,7′-dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]biphenyl-2-carboxylic acid 7144 Acide 4′-[(1,7′-diméthyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)méthyl]-2-biphénylcarboxylique [French] [ACD/IUPAC Name] acide 4′-[(1,7′-diméthyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)méthyl]biphényl-2-carboxylique [French] Kin­zal­mono [Trade name] Micardis [Trade name] Pri­tor [Trade name] telmis­ar­tan [French] [INN] Telmis­ar­tan [INN] [JAN] [USAN] [Wiki] telmis­artán [Span­ish] [INN] telmis­ar­tanum [Latin] [INN] U5SYW473RQ телмисартан [Russ­ian] [INN] تيلميسارتان [Ara­bic] [INN] 替米沙坦 [Chi­nese] [INN] (1,1′-Biphenyl)-2-carboxylic acid, 4′-((1,4′-dimethyl-2′-propyl(2,6′-bi-1H-benzimidazol)-1′-yl)methyl)- [1,1′-biphenyl]-2-carboxylic acid, 4′[(1,4′-dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl] [144701-48-4] 1189889-44-8 [RN] 2-(4-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid 2-[4-[[4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]phenyl]benzoic acid 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid 2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-benzimidazol-1-yl]methyl]phenyl]benzoic acid 2-[4-[[4-methyl-6-(1-methylbenzoimidazol-2-yl)-2-propyl-benzoimidazol-1-yl]methyl]phenyl]benzoic acid 4′-((1,4′-dimethyl-2′-propyl(2,6′-bi-1H-benzimidazol)-1′-yl)methyl)-(1,1′-biphenyl)-2-carboxylic acid 4-((1,7-dimethyl-2-propyl-1h,3h-[2,5-bibenzo[d]imidazol]-3-yl)methyl)-[1,1-biphenyl]-2-carboxylic acid 4′-((1,7′-dimethyl-2′-propyl-1H,3’H-[2,5′-bibenzo[d]imidazol]-3′-yl)methyl)-[1,1′-biphenyl]-2-carboxylic acid 4′-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid 4-(1,4-Dimethyl-2-propyl-2,6-bi-1H-benzimidazol-1-yl)methyl-1,1-biphenyl-2-carboxylicacid 4′-(1,7′-Dimethyl-2′-propyl-1H-[2,5′]bibenzoimidazolyl-3′-ylmethyl)-biphenyl-2-carboxylic acid 4′-?[(1,?4′-?DIMETHYL-?2′-?PROPYL[2,?6′-?BI-?1H-?BEN­Z­IM­I­DA­ZOL]-?1′-?YL)METHYL]-?[1,?1′-?BIPHENYL]-?2-?CAR­BOXYLIC ACID 4′-[(1,4′-dimethyl-2’propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]-[1,1′-biphenyl]-2-carboxylic acid 4′-[(1,4′-dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl]-[1,1′-biphenyl]-2-carboxylic acid 4′[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid 4′-[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid 4′-[(1,7′-dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid 4-[(1,7-dimethyl-2-propyl-1h,3h-2,5-bibenzimidazol-3-yl)methyl]biphenyl-2-carboxylic acid 4′[(1,7′-dimethyl-2′-propyl-1H,3’H-2,5′-bibenzimidazol-3′-yl)methyl]biphenyl-2-carboxylic acid 4′-[[1,4′-Dimethyl-2′-propyl(2,6′-bi-1H-benzimidazol)-1′-yl]-methyl]-1,1′-biphenyl-2-carboxylic acid 1,1-dimethylethyl ester 4′-[[4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl]methyl]-2-biphenylcarboxylic acid 4′[(1,4′-Dimethyl-2′-propyl[2,6′-bi-1H-benzimidazol]-1′-yl)methyl][1,1′-biphenyl]-2-carboxylic acid 6624054 [Beil­stein] BAY-68-9291 BIBR 277 SE BIBR 277;Micardis;Pritor;Telday BIBR 277SE BIBR277 BIBR-277SE BIBR-277-SE BR-72892 BSPBio_​002738 C33H30N4O2 Car­bon monox­ide releas­ing mol­e­cule 3 | DV2037500 Kin­zal MFCD00918125 [MDL num­ber] Micardis (TN) MICARDIS HCT Micardis® MLS000759432 NCGC00095150-01 NCGC00095150-02 Phar­­makon1600-01505261 Pri­tor® SMR000466326 SPECTRUM1505261 Spectrum5_​001053 Tar­git Targit;Temax ;BIBR277;Micardis Tel­day Tele­act D Tel­ma Telmis­ar­tan (JAN/USAN/INN) Telmis­ar­tan (Micardis) TELMIS­AR­­TAN-D3 Telmisat­tan Temax TL8000991 TLS UNII :U5SYW473RQ UNII-U5SY­W473RQ

Mol­e­c­u­lar Structure

SMILES

CCCc1nc2c(cc(cc2n1Cc3ccc(cc3)c4ccccc4C(=O)O)c5nc6ccccc6n5C)C

Std­InChI

InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)

Std­InChIKey

RMMXLEN­WKU­U­MAY-UHF­F­­FAOYSA-N

Mol­e­c­u­lar Formula

C33H30N4O2

Mol­e­c­u­lar Weight

514.62

MDL Number

MFCD00918125

Safe­ty Data

Per­son­al Pro­tec­tive Equipment

Eye­shields, Gloves, type N95 (US), type P1 (EN143) res­pi­ra­tor fil­ter

RIDADR

NONH for all modes of trans­port

WGK Germany

2 

Spec­i­fi­ca­tions and Oth­er Infor­ma­tion of Our Telmis­ar­tan CAS 144701-48-4

Stan­dard

EP, USP

GMP

LCF­DA

Basic Patent Situation

US expiry date	20140107
EU expiry date	20120131 (20170130)
JP expiry date	20170125

Pack­age

Accord­ing to cus­tomer require­ments to pack­ag­ing

Stor­age

Under the room tem­per­a­ture and away from light

Appli­ca­tion

Used as the Angiotensin II Recep­tor Antag­o­nist.

Links

This prod­uct is devel­oped by our R&D com­pa­ny Wat­son­noke Sci­en­tif­ic Ltd(http://​www​.wat​son​noke​.com/), and here is the cor­re­spond­ing linkhttp://​www​.wat​son​noke​.com/​t​e​l​m​i​s​a​r​t​a​n​-​c​a​s​-​1​4​4​7​0​1​-​4​8​-4/

Quick Inquiry

Fill out our inquiry form and one of our experts will be in touch with you short­ly (Please change screen to hor­i­zon­tal for com­plete brows­ing if you are check­ing Wat­son on your mobile phone).